Skip to main content
Erschienen in: AIDS and Behavior 6/2011

01.08.2011 | Original Paper

Longitudinal Association of HIV Conspiracy Beliefs with Sexual Risk Among Black Males Living with HIV

verfasst von: Laura M. Bogart, Frank H. Galvan, Glenn J. Wagner, David J. Klein

Erschienen in: AIDS and Behavior | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Research is needed to identify culturally relevant factors that may contribute to sexual risk among African Americans. We investigated HIV-specific medical mistrust as one such cultural factor, often exhibited as conspiracy beliefs about HIV (e.g., “AIDS was produced in a government laboratory”), which may be indicative of general suspicion of HIV treatment and prevention messages. Over a 6-month time-period, we measured endorsement of HIV conspiracy beliefs three times and frequency of condom use monthly among 181 HIV-positive African American males. A hierarchical multivariate repeated-measures logistic random effects model indicated that greater belief in HIV conspiracies was associated with a higher likelihood of reporting unprotected intercourse across all time-points. An average of 54% of participants who endorsed conspiracies reported unprotected intercourse, versus 39% who did not endorse conspiracies. Secondary prevention interventions may need to address medical mistrust as a contributor to sexual risk among African Americans living with HIV.
Literatur
2.
Zurück zum Zitat Mitsch A, Hu X, Harrison KM, Durant T. Trends in HIV/AIDS diagnoses among men who have sex with men–33 states, 2001–2006. MMWR Morb Mortal Wkly Rep. 2008;57(25):681–6. Mitsch A, Hu X, Harrison KM, Durant T. Trends in HIV/AIDS diagnoses among men who have sex with men–33 states, 2001–2006. MMWR Morb Mortal Wkly Rep. 2008;57(25):681–6.
3.
Zurück zum Zitat Centers for Disease Control and Prevention. Subpopulation estimates from the HIV incidence surveillance system–United States, 2006. MMWR Morb Mortal Wkly Rep. 2008;57(36):985–9. Centers for Disease Control and Prevention. Subpopulation estimates from the HIV incidence surveillance system–United States, 2006. MMWR Morb Mortal Wkly Rep. 2008;57(36):985–9.
4.
Zurück zum Zitat Dean HD, Steele CB, Satcher AJ, Nakashima AK. HIV/AIDS among minority races and ethnicities in the United States, 1999–2003. J Natl Med Assoc. 2005;97(7 Suppl):5S–12S.PubMed Dean HD, Steele CB, Satcher AJ, Nakashima AK. HIV/AIDS among minority races and ethnicities in the United States, 1999–2003. J Natl Med Assoc. 2005;97(7 Suppl):5S–12S.PubMed
5.
Zurück zum Zitat Sifakis F, Flynn CP, Metsch LR, LaLota M, Murrill C, Koblin BA, et al. HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men–five US cities, June 2004-April 2005. MMWR Morb Mortal Wkly Rep. 2005;54(24):597–601. Sifakis F, Flynn CP, Metsch LR, LaLota M, Murrill C, Koblin BA, et al. HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men–five US cities, June 2004-April 2005. MMWR Morb Mortal Wkly Rep. 2005;54(24):597–601.
6.
Zurück zum Zitat Bing EG, Bingham T, Millett GA. Research needed to more effectively combat HIV among African-American men who have sex with men. J Natl Med Assoc. 2008;100(1):52–6.PubMed Bing EG, Bingham T, Millett GA. Research needed to more effectively combat HIV among African-American men who have sex with men. J Natl Med Assoc. 2008;100(1):52–6.PubMed
7.
Zurück zum Zitat Landrine H, Klonoff EA. Cultural diversity and health psychology. In: Baum A, Singer J, Revenson T, editors. Handbook of health psychology. Mahwah, NJ: Erlbaum; 2001. p. 855–95. Landrine H, Klonoff EA. Cultural diversity and health psychology. In: Baum A, Singer J, Revenson T, editors. Handbook of health psychology. Mahwah, NJ: Erlbaum; 2001. p. 855–95.
8.
Zurück zum Zitat Brandon DT, Isaac LA, LaVeist TA. The legacy of Tuskegee and trust in medical care: is Tuskegee responsible for race differences in mistrust of medical care? J Natl Med Assoc. 2005;97(7):951–6.PubMed Brandon DT, Isaac LA, LaVeist TA. The legacy of Tuskegee and trust in medical care: is Tuskegee responsible for race differences in mistrust of medical care? J Natl Med Assoc. 2005;97(7):951–6.PubMed
9.
Zurück zum Zitat Armstrong K, Ravenell KL, McMurphy S, Putt M. Racial/ethnic differences in physician distrust in the United States. Am J Public Health. 2007;97(7):1283–9.PubMedCrossRef Armstrong K, Ravenell KL, McMurphy S, Putt M. Racial/ethnic differences in physician distrust in the United States. Am J Public Health. 2007;97(7):1283–9.PubMedCrossRef
10.
Zurück zum Zitat Armstrong K, McMurphy S, Dean LT, Micco E, Putt M, Halbert CH, et al. Differences in the patterns of health care system distrust between blacks and whites. J Gen Intern Med. 2008;23(6):827–33.PubMedCrossRef Armstrong K, McMurphy S, Dean LT, Micco E, Putt M, Halbert CH, et al. Differences in the patterns of health care system distrust between blacks and whites. J Gen Intern Med. 2008;23(6):827–33.PubMedCrossRef
11.
Zurück zum Zitat Ross MW, Essien EJ, Torres I. Conspiracy beliefs about the origin of HIV/AIDS in four racial/ethnic groups. J Acquir Immune Defic Syndr. 2006;41(3):342–4.PubMedCrossRef Ross MW, Essien EJ, Torres I. Conspiracy beliefs about the origin of HIV/AIDS in four racial/ethnic groups. J Acquir Immune Defic Syndr. 2006;41(3):342–4.PubMedCrossRef
12.
Zurück zum Zitat Bogart LM, Thorburn S. Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? J Acquir Immune Defic Syndr. 2005;38(2):213–8.PubMedCrossRef Bogart LM, Thorburn S. Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? J Acquir Immune Defic Syndr. 2005;38(2):213–8.PubMedCrossRef
13.
Zurück zum Zitat Bogart LM, Wagner G, Galvan FH, Banks D. Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among African American men with HIV. J Acquir Immune Defic Syndr. 2010;53(5):648–55.PubMed Bogart LM, Wagner G, Galvan FH, Banks D. Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among African American men with HIV. J Acquir Immune Defic Syndr. 2010;53(5):648–55.PubMed
14.
Zurück zum Zitat Bogart LM, Wagner GJ, Galvan FH, Klein DJ. Longitudinal relationships between antiretroviral treatment adherence and discrimination due to HIV-serostatus, race, and sexual orientation among African-American men with HIV. Ann Behav Med. 2010;Epub. Bogart LM, Wagner GJ, Galvan FH, Klein DJ. Longitudinal relationships between antiretroviral treatment adherence and discrimination due to HIV-serostatus, race, and sexual orientation among African-American men with HIV. Ann Behav Med. 2010;Epub.
15.
Zurück zum Zitat Fitzmaurice GM, Lipsitz SR, Ware JH. Applied longitudinal analysis. New York: Wiley; 2004. Fitzmaurice GM, Lipsitz SR, Ware JH. Applied longitudinal analysis. New York: Wiley; 2004.
16.
Zurück zum Zitat Williams DR, Allen S, Padian N. Project Eban: a giant step forward. J Acquir Immune Defic Syndr. 2008;49:S1–2.PubMedCrossRef Williams DR, Allen S, Padian N. Project Eban: a giant step forward. J Acquir Immune Defic Syndr. 2008;49:S1–2.PubMedCrossRef
17.
Zurück zum Zitat Wilton L, Herbst JH, Coury-Doniger P, Painter TM, English G, Alvarez ME, et al. Efficacy of an HIV/STI prevention intervention for black men who have sex with men: findings from the Many Men, Many Voices (3MV) project. AIDS Behav. 2009;13:532–44.PubMedCrossRef Wilton L, Herbst JH, Coury-Doniger P, Painter TM, English G, Alvarez ME, et al. Efficacy of an HIV/STI prevention intervention for black men who have sex with men: findings from the Many Men, Many Voices (3MV) project. AIDS Behav. 2009;13:532–44.PubMedCrossRef
18.
Zurück zum Zitat Jones KT, Gray P, Whiteside YO, Wang T, Bost D, Dunbar E, et al. Evaluation of an HIV prevention intervention adapted for Black men who have sex with men. Am J Public Health. 2008;98(6):1043–50.PubMedCrossRef Jones KT, Gray P, Whiteside YO, Wang T, Bost D, Dunbar E, et al. Evaluation of an HIV prevention intervention adapted for Black men who have sex with men. Am J Public Health. 2008;98(6):1043–50.PubMedCrossRef
19.
Zurück zum Zitat NIMH Multisite HIV/STD Prevention Trial for African American Couples Group. Methodological overview of an African American couple-based HIV/STD prevention trial. J Acquir Immune Defic Syndr. 2008;49:S3–14.CrossRef NIMH Multisite HIV/STD Prevention Trial for African American Couples Group. Methodological overview of an African American couple-based HIV/STD prevention trial. J Acquir Immune Defic Syndr. 2008;49:S3–14.CrossRef
20.
Zurück zum Zitat Wyatt GE. Enhancing cultural and contextual intervention strategies to reduce HIV/AIDS among African Americans. Am J Public Health. 2009;99(11):1941–5.PubMedCrossRef Wyatt GE. Enhancing cultural and contextual intervention strategies to reduce HIV/AIDS among African Americans. Am J Public Health. 2009;99(11):1941–5.PubMedCrossRef
21.
Zurück zum Zitat Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepatz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. J Acquir Immune Defic Syndr. 2006;43(1):S23–35.PubMedCrossRef Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepatz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. J Acquir Immune Defic Syndr. 2006;43(1):S23–35.PubMedCrossRef
22.
Zurück zum Zitat Simoni JM, Frick PA, Pantalone DW, Turner BJ. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003;11(6):185–98.PubMed Simoni JM, Frick PA, Pantalone DW, Turner BJ. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003;11(6):185–98.PubMed
23.
Zurück zum Zitat Mize SJ, Robinson BE, Bockting WO, Scheltema KE. Meta-analysis of the effectiveness of HIV prevention interventions for women. AIDS Care. 2002;14(2):163–80.PubMedCrossRef Mize SJ, Robinson BE, Bockting WO, Scheltema KE. Meta-analysis of the effectiveness of HIV prevention interventions for women. AIDS Care. 2002;14(2):163–80.PubMedCrossRef
24.
Zurück zum Zitat Logan TK, Cole J, Leukefeld C. Women, sex, and HIV: social and contextual factors, meta-analysis of published interventions, and implications for practice and research. Psychol Bull. 2002;128(6):851–85.PubMedCrossRef Logan TK, Cole J, Leukefeld C. Women, sex, and HIV: social and contextual factors, meta-analysis of published interventions, and implications for practice and research. Psychol Bull. 2002;128(6):851–85.PubMedCrossRef
Metadaten
Titel
Longitudinal Association of HIV Conspiracy Beliefs with Sexual Risk Among Black Males Living with HIV
verfasst von
Laura M. Bogart
Frank H. Galvan
Glenn J. Wagner
David J. Klein
Publikationsdatum
01.08.2011
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 6/2011
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9796-7

Weitere Artikel der Ausgabe 6/2011

AIDS and Behavior 6/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.